A closer examination of the Cell and Gene Therapy CDMO Market reveals insights into its burgeoning potential, with current valuations set at USD 35.89 billion in 2024 and an anticipated surge to USD 366.93 billion by 2035. This phenomenal growth, represented by a CAGR of 23.53%, indicates a substantial shift in market dynamics driven by technological innovations and the burgeoning demand for...